ReviewJournal of cannabis research2025
The cannabis-mind connection: a clinician's perspective on mental health practice, harm reduction, and racial equity.
Review in Journal of cannabis research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabis is increasingly part of the mental health landscape, yet clinical practice has not kept pace with patient use. Many individuals rely on cannabis for anxiety, trauma, and mood concerns, often without professional guidance. Persistent stigma, limited training, and the racialized legacy of prohibition create barriers that prevent open dialogue in therapy and undermine patient trust. MAIN BODY: This perspective highlights the disconnect between patient experiences and clinical engagement with cannabis. Drawing on historical context, clinical insight, and emerging evidence, it considers how systemic inequities and professional discomfort shape current practice. Black and Brown communities have borne disproportionate harms from cannabis criminalization, influencing how cannabis use is perceived and discussed within care settings. A harm reduction and person-centered approach provides a framework for clinicians to engage with patients in a more ethical and effective manner. This includes acknowledging cannabis use without judgment, exploring patients’ intentions and experiences, and supporting informed decisions about risks and benefits. Cultural humility and awareness of cannabis’s historical and therapeutic roles are essential to counteracting stigma and building safety in the therapeutic relationship. By moving beyond abstinence-only models, clinicians can foster transparency and trust while respecting patient autonomy.
conclusionClinicians need not endorse cannabis to engage meaningfully with patients. What is required is openness, informed practice, and recognition of the structural forces that shape patient behavior and disclosure. Approaching cannabis use as a valid subject of clinical conversation advances justice-oriented care and creates opportunities for more responsive and inclusive mental health practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.